The results for enicepatide reinforce the company’s ambitions to rapidly develop its portfolio of medicines for people with obesity, diabetes and cardiovascular disease.
Source link
About The Author
Roche Says Drug Helped Patients Reduce Blood-Sugar Levels, Weight in Trial